Gastric cytoprotection by prostaglandin E2 and prostacyclin: Relationship to ep1 and ip receptors

Journal of Physiology and Pharmacology

Volumn 65, Issue 1, 2014, Pages 3-14

  Takeuchi, Koji ^a,b,c  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^c General Incorporated Association Kyoto Research Center for Gastrointestinal Diseases   (Japan)

Author keywords

Alkaline secretion; Capsaicin; Cyclooxygenase; Cytoprotection; EP receptor subtype; Gastrointestinal mucosa; Hydrochloric acid; Prostacyclin; Prostaglandin E

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTITHROMBOCYTIC AGENT; ATROPINE; BICARBONATE; BUTAPROST; CAPSAICIN; CIMETIDINE; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYDROCHLORIC ACID; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IRRITANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTACYCLIN; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; SULPROSTONE; TAUROCHOLIC ACID;

ACID SECRETION; CELL PROTECTION; DOSE RESPONSE; ENTEROCHROMAFFIN LIKE CELL; GASTROINTESTINAL HEMORRHAGE; HUMAN; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REVIEW; SENSORY NERVE; STOMACH INJURY; STOMACH MOTILITY; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCOSA LESION; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOPROTECTION; DINOPROSTONE; EPOPROSTENOL; ETHANOL; GASTRIC MUCOSA; HUMANS; RECEPTORS, PROSTAGLANDIN;

EID: 84896880571     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Miller TA. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601-G623.
2. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77: 433-443.
3. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 1983; 245: G113-G121.
4. Takeuchi K, Ohono T, Okabe S. Irritative and protective activity of mild irritants in rat stomach. Dig Dis Sci 1987; 32: 889-896.
5. Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. Prostanoids and their receptors. In: Comprehensive Medicinal Chemistry, Membranes and Receptors. Vol. 3. JC Emmett (ed). Oxford, Pergamon Press, 1990, pp. 643-714.
6. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structure, properties and functions. Physiol Rev 1999; 79: 1193-1226.
7. Araki H, Ukawa H, Sugawa Y, Yagi K, Suzuki K, Takeuchi K. Roles of prostaglandin E receptor subtypes in cytoprotective action of prostaglandin E2 in rat stomach. Aliment Pharmacol Ther 2000; 14 (Suppl. 1): 116-124.
8. Suzuki K, Araki H, Mizoguchi H, Furukawa O, Takeuchi K. Prostaglandin E inhibits indomethacin-induced gastric lesions through EP1 receptors. Digestion 2001; 63: 92-101.
9. Takeuchi K, Araki H, Umeda M, Komoike Y, Suzuki K. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: A study using rats and knockout mice. J Pharmacol Exp Ther 2001; 297: 1160-1165.
10. Sugimoto Y, Namba T, Honda A, et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem 1992; 267: 6463-6466.
11. Watabe A, Sugimoto Y, Honda A, et al. Cloning and expression of cDNAfor a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 1993; 27: 20175-20178.
12. Takeuchi K, Yagi K, Kato S, Ukawa H. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology 1997; 113: 1553-1559.
13. Takeuchi K, Ukawa H, Kato S, et al. Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E receptor subtype EP3. Gastroenterology 1999; 117: 1128-1135.
14. Takeuchi K, Kato S, Takeeda M, Ogawa Y, Nakashima M, Matsumoto M. Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection in rodents through EP2 and IP receptors. J Pharmacol Exp Ther 2003; 304: 1055-1062.
15. Hoshino T, Tsutsumi S, Tomisato W, Hwang HJ, Tsuchiya T, Mizushima T. Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J Biol Chem 2003; 278: 12752-12758.
16. Murakami T, Tanigami M, Amagase K, Takeuchi K. Adaptive gastric cytoprotection is mediated by prostaglandin E receptor EP1 but not EP4 subtype. Gastroenterology 2012; 142 (Suppl. 1): 496
17. Aoi M, Aihara E, Nakashima M, Takeuchi K. Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats. Am J Physiol 2004; 287: G96-G103.
18. Takeuchi K, Tanaka A, Kato S, Aihara E, Amagase K. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy) benzamido) ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa. J Pharmacol Exp Ther 2007; 322: 903-912.
19. Yamamoto H, Tanaka A, Kunikata T, Hirata T, Kato S, Takeuchi K. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs. J Physiol (Paris) 1999; 93: 405-412.
20. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 828-839.
21. Ehrlich K, Plate S, Stroff T, Gretzer B, Respondek M, Peskar BM. Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2. Am J Physiol 1998; 274: G955-G964.
22. Fukushima K, Aoi Y, Kato S, Takeuchi K. Gastroprotective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J Gastroenterol 2006; 12: 3031-3037.
23. Takeuchi K, Niida H, Matsumoto J, Ueshima K, Okabe S. Gastric motility changes in capsaicin-induced cytoprotection in the rat stomach. Jpn J Pharmacol 1991; 55: 147-155.
24. Uchida M, Yano S, Watanabe K. The role of capsaicinsensitive afferent nerves in protective effect of capsaicin against absolute ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1991; 55: 279-282.
25. Takeuchi K, Kato S, Ogawa Y, Kanatsu K, Umeda M. Role of endogenous prostacyclin in gastric ulcerogenic and healing responses: a study using IP-receptor knockout mice. J Physiol (Paris) 2001; 95: 75-80.
26. Boku K, Ohno T, Saeki T, et al. Adaptive cytoprotection mediated by prostaglandin I2 is attributable to sensitization of CGRP-containing sensory nerves. Gastroenterology 2001; 120: 134-143.
27. Tashima K, Nakashima M, Kagawa S, Kato S, Takeuchi K. Gastric hyperemic response induced by acid back-diffusion in rat stomachs following barrier disruption: relation to vanilloid type-1 receptors. Med Sci Monit 2002; 8: BR157-BR163.
28. Takeuchi K, Ohashi Y, Kohmoto M, Oka H, Nomura Y, Aihara E. Gender difference in duodenal HCO3-response to mucosal acidification: Importance of up-regulation of ASIC3 by estradiol. Gastroenterology 2012; 142 (Suppl. 1): S-202-S-203.
29. Takeuchi K, Ueki S, Okabe S. Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 1986; 31: 1114-1122.
30. Takeuchi K. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol 2012; 18: 2147-2160.
31. Suzuki K, Araki H, Komoike Y, Takeuchi K. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats. Med Sci Moni 2000; 6: 908-914.
32. CAPRIE Steering Committee. Arandomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
33. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006; 333: 726.
34. Izuhara C, Yamasaki K, Honda M, Nishio H, Takeuchi K. Aggravation by clopidogrel, an antiplatelet drug, of HCl/aspirin-induced gastric bleeding and lesions in rats: prophylactic effect of rebamipide. Jpn Pharmacol Ther 2010; 38: 333-345.
35. Takayama S, Izuhara C, Yamada N, et al. A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs. J Physiol Pharmacol 2012; 63: 41-52.
36. Takeuchi K, Komoike Y, Takeeda M, Ukawa H. Gastric mucosal ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Aliment Pharmacol Ther 2002; 16: 74-82.
37. Kagawa S, Aoi M, Nakashima M, Kubo Y, Kotani T, Takeuchi K. Stimulation by capsaicin of duodenal HCO3-secretion via afferent neurons and vanilloid receptors in rats: comparison with acid-induced HCO3-response. Dig Dis Sci 2003; 48: 1850-1856.
38. Yokotani K, Okuma Y, Osumi Y. Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane-anesthetized rats. Br J Pharmacol 1996; 117: 653-656.
39. Ohno T, Katori M, Majima M, et al. Dilatation and constriction of rat gastric mucosal microvessels through prostaglandin EP2 and EP3 receptors. Aliment Pharmacol Ther 1999; 13: 1243-1250.
40. Takahashi S, Takeuchi K, Okabe S. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem Pharmacol 1999; 58: 1997-2002.
41. Kato S, Aihara E, Yoshii K, Takeuchi K. Dual action of prostaglandin E2 on gastric acid secretion through different EP receptor subtypes in the rat. Am J Physiol 2005; 289: G64-G69.
42. Takeuchi K, Ukawa H, Furukawa O, et al. Prostaglandin E receptor subtypes involved in gastroduodenal bicarbonate secretion. J Physiol Pharmacol 1999; 50: 155-168.
43. Kita K, Takahashi K, Ohashi Y, Takasuka H, Aihara E, Takeuchi K. Phosphodiesterase isozymes involved in regulation of HCO3-secretion in isolated mouse stomach in vitro. J Pharmacol Exp Ther 2008; 326: 889-896.
44. Mersereau WA, Hinchey EJ. Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982; 91: 150-155.
45. Takeuchi K, Matsumoto J, Ueshima K, Okabe S. Gastric motility changes in the cytoprotective action of N-ethylmaleimide and capsaicin in the rat stomach. In: Frontiers of Mucosal Immunology, Tsuchiya M (ed). New York, Elsevier Science Publisher, 1991, pp. 581-584.
46. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S. Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Relation to gastric hypermotility. Digestion 1991; 49: 175-184.
47. Okada M, Niida H, Takeuchi K, Okabe S. Role of prostaglandin deficiency in pathogenic Mechanism of gastric lesions induced by indomethacin in rats. Dig Dis Sci 1989; 34: 694-702.
48. Milenov K, Golenhofen K. Contractile responses of longitudinal and circular smooth muscle of the canine stomach to prostaglandin E2 and F2a. Prostaglandins Leukot Med 1982; 8: 287-300.
49. Ding M, Kinoshita Y, Kishi K, et al. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins 1997; 53: 199-216.
50. Morimoto K, Sugimoto Y, Katsuyama M, et al. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol 1997; 272: G681-G687.
51. Wallace JL, Granger DN. Pathogenesis of NSAID gastropathy; are neutrophils the culpris? Trends Pharmacol Sci 1992; 13: 129-131.
52. Armstrong RA. Investigation of inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 1995; 116: 2903-2908.
53. Melange R, Gentry C, Toseland N, Smith PH, Fuller J. Neutropenia does not prevent etodolac-or indomethacininduced gastrointestinal damage in the rat. Dig Dis Sci 1995; 40: 2694-2703.
54. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K. Cyclooxygenase isozymes in acute mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 1997; 122: 447-454.
55. Takeeda M, Yamato M, Kato S, Takeuchi K. Cyclooxygenase isozymes involved in adaptive functional responses in rat stomachs following barrier disruption. J Pharmacol Exp Ther 2003; 307: 713-719.
56. Komoike Y, Nakashima M, Nakagiri A, Takeuchi K. Prostaglandin E receptor EP1 subtype but not IP receptor involved in mucosal blood flow response of mouse stomachs following barrier disruption. Digestion 2003; 67: 186-194.
57. Haupt W, Jiang W, Kreis ME, Grundy D. Prostaglandin EP receptor subtypes have distinctive effects on jejunal afferent sensitivity in the rat. Gastroenterology 2000; 119: 1580-1589.
58. Hase S, Yokota A, Nakagiri A, Takeuchi K. Prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats through EP1 receptors. Life Sci 2003; 74: 629-641.
59. Szabo S. Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 1991; 13(Suppl. 2): S21-S34.
60. Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K. 16,16-Dimetyl prostaglandin E7 inhibits indomethacininduced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 2002; 47: 894-904.
61. Aoi Y, Terashima S, Ogura M, Nishio H, Kato S, Takeuchi K. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. J Physiol Pharmacol 2008; 59: 315-336.
62. Takeuchi K, Tanigami M, Amagase K, Ochi A, Hatazawa R. Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors. J Gastroenterol Hepatol 2010; 25(Suppl. 1): S67-S74.